Education
About Us
Working with TipRanks
Follow Us
Essity AB (ETTYF)
OTHER OTC:ETTYF
ETTYF Stock Chart & Stats
$27.78
-$1.35(-5.13%)
At close: 4:00 PM EST
$27.78
-$1.35(-5.13%)
Day’s Range― - ―
52-Week Range$23.78 - $32.97
Previous CloseN/A
Volume2.06K
Average Volume (3M)45.00
Market Cap
$20.28B
Enterprise Value$212.14B
Total Cash (Recent Filing)$9.75B
Total Debt (Recent Filing)$38.63B
Price to Earnings (P/E)14.4
Beta>-0.01
Next Earnings
Apr 23, 2026EPS Estimate
0.49Next Dividend Ex-DateN/A
Dividend Yield2.6%
Share Statistics
EPS (TTM)0.51
Shares Outstanding635,853,800
10 Day Avg. Volume137
30 Day Avg. Volume45
Financial Highlights & Ratios
PEG Ratio-0.38
Price to Book (P/B)2.13
Price to Sales (P/S)1.32
P/FCF Ratio21.83
Enterprise Value/Market Cap10.46
Enterprise Value/Revenue1.53
Enterprise Value/Gross Profit4.60
Enterprise Value/Ebitda8.25
Forecast
1Y Price Target
$29.68Price Target Upside6.85% Upside
Rating ConsensusHold
Number of Analyst Covering3
EPS Forecast (FY)2.14
Revenue Forecast (FY)$14.96B
Bulls Say, Bears Say
Bulls Say
Margin Expansion And Profitability RecoverySustained margin expansion to 14.1% signals structural improvement in cost base and pricing execution. Higher operating margins support durable free cash flow, fund buybacks/dividends and reinvestment into A&P and innovation, improving resilience versus cyclical revenue swings.
Improved Leverage And Consistent Cash GenerationMarked deleveraging and net debt/EBITDA near 1.0 plus recurring positive free cash flow increase financial flexibility. This stronger balance-sheet footing supports strategic M&A, ongoing buybacks and higher dividend policy while reducing refinancing and liquidity risk.
Strategic M&A, Share Gains And Product InnovationThe Edgewell deal and consistent market-share gains materially scale U.S. personal-care exposure and raise branded mix. Coupled with product upgrades and innovation in Health & Medical, this strengthens structural growth avenues and margin uplift potential across core categories.
Bears Say
Choppy Revenue And Category Volume DeclinesPersistent revenue softness and category volume declines (notably Baby Care and Consumer Tissue) indicate structural demand pressures. Reduced volumes can erode scale, raise per-unit costs and limit the ability to sustain pricing, constraining long-term top-line recovery.
Price/mix Headwinds And Promotional PressureNegative price/mix and higher promotional intensity, plus lost private-label contracts, weaken pricing power. If sustained, this compresses margins and forces reinvestment in A&P or promotions to defend share, limiting net margin durability despite cost savings.
Unusual 2025 Debt Reporting Reduces ComparabilityAnomalous 2025 debt reporting complicates trend analysis of leverage and liquidity. This opacity raises uncertainty about true financial flexibility and capital structure risk, making medium-term assessment of funding capacity and covenant exposure less reliable.
Essity AB News
ETTYF FAQ
What was Essity AB’s price range in the past 12 months?
Essity AB lowest stock price was $23.78 and its highest was $32.97 in the past 12 months.
What is Essity AB’s market cap?
Essity AB’s market cap is $20.28B.
When is Essity AB’s upcoming earnings report date?
Essity AB’s upcoming earnings report date is Apr 23, 2026 which is in 48 days.
How were Essity AB’s earnings last quarter?
Essity AB released its earnings results on Jan 22, 2026. The company reported $0.509 earnings per share for the quarter, missing the consensus estimate of $0.526 by -$0.016.
Is Essity AB overvalued?
According to Wall Street analysts Essity AB’s price is currently Undervalued.
Does Essity AB pay dividends?
Essity AB pays a Annually dividend of $0.821 which represents an annual dividend yield of 2.6%. See more information on Essity AB dividends here
What is Essity AB’s EPS estimate?
Essity AB’s EPS estimate is 0.49.
How many shares outstanding does Essity AB have?
Essity AB has 635,853,800 shares outstanding.
What happened to Essity AB’s price movement after its last earnings report?
Essity AB reported an EPS of $0.509 in its last earnings report, missing expectations of $0.526. Following the earnings report the stock price went down -4.313%.
Which hedge fund is a major shareholder of Essity AB?
Currently, no hedge funds are holding shares in ETTYF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Essity AB
Essity AB (publ) develops, produces, and sells hygiene and health products and services worldwide. It offers health and medical products, including incontinence products, wound care, compression therapy, orthopedics, skincare products, and digital solutions with sensor technology. It operates in Personal Care, Consumer Tissue, Professional Hygiene, and Other segments. The company also provides consumer goods, such as incontinence products, pads, diapers, wet wipes, skincare products, intimate soaps, washable absorbent underwear, menstrual cups, toilet papers, household towels, handkerchiefs, facial tissues, and napkins; and professional hygiene products that consist of toilet papers, paper hand towels, napkins, hand soaps, hand lotions, hand sanitizers, dispensers, and cleaning and wiping products. In addition, it offers digital solutions, such as Internet of Things sensor technology enabling data-driven cleaning, as well as related service and maintenance to companies and office buildings, universities, healthcare facilities, industries, restaurants, hotels, stadiums, and other public venues. The company markets its health and medical products under the TENA, Leukoplast, Cutimed, JOBST, Actimove, and Delta-Castbrands brands through pharmacies, medical devices stores, hospitals, distributors, and care institutions, as well as e-commerce; consumer goods products under the Libero, Libresse, Nosotras, Saba, TOM Organic, Lotus, Regio, Tempo, and Vinda brands through retail trade and online; and professional hygiene products under the TORK brand through distributors and online. It serves in Europe, North America, Latin America, Asia, and internationally. Essity AB (publ) was founded in 1849 and is headquartered in Stockholm, Sweden.
ETTYF Company Deck
ETTYF Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented a predominantly constructive operational and financial picture: strong margin expansion, substantial COGS tailwinds and realized cost savings, solid cash flow and balance-sheet metrics (net debt/EBITDA ~1.0), successful strategic M&A and clear market-share gains and product innovation momentum—particularly in Health & Medical, Incontinence and premium Professional Hygiene. Offsetting these positives are continuing end-market headwinds in Baby and Consumer Tissue (volume declines of ~4% and ~2% respectively), negative price/mix in the quarter (~-0.9%), some one-off rebate impacts (Latin America Feminine), lost private-label contracts and the near-term costs of the restructuring program. Management’s messaging emphasizes agility, reinvestment of savings into A&P to drive volume, a disciplined M&A stance, and confidence in returning to stronger profitable volume growth in 2026. On balance, the positive margin, cash and strategic momentum outweigh the category-specific volume challenges and temporary pricing effects.View all ETTYF earnings summariesETTYF Net sales Breakdown
54.31% Consumer Goods
26.83% Professional Hygiene
18.84% Health & Medical
0.02% Other
ETTYF Stock 12 Month Forecast
Average Price Target
$29.68
▲(6.85% Upside)
Technical Analysis
Ownership Overview
―
Insiders
7.09% Mutual Funds
0.20% Other Institutional Investors
78.86% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---